立方制药: 关于股东减持计划实施完毕的公告

Summary of Key Points Core Viewpoint - The announcement details the completion of a share reduction plan by shareholder Gao Meihua, who reduced her holdings in Hefei Lifan Pharmaceutical Co., Ltd. by 300,000 shares, representing 0.16% of the company's total share capital [1]. Shareholder Reduction Details - Gao Meihua executed the share reduction from July 28, 2025, to August 29, 2025, at an average price of 29.71 yuan per share [1]. - The reduction price ranged from 27.44 yuan to 37.00 yuan per share [1]. - Prior to the reduction, Gao Meihua held 6,444,703 shares (3.37% of total share capital), and after the reduction, she holds 6,144,703 shares (3.23% of total share capital) [1]. Compliance and Future Plans - The share reduction was consistent with previously disclosed intentions and plans, adhering to relevant regulations and guidelines [1]. - Gao Meihua has committed to considering personal and family financial needs before any future share reductions, with a requirement to announce any such plans three trading days in advance [1].